What is EPKINLY?

EPKINLY is the first-of-its-kind bispecific antibody treatment for certain types of DLBCL that returned or didn't respond after 2 or more prior treatments

EPKINLY is different from chemotherapy or stem cell therapy. It is a bispecific antibody that works by harnessing the power of your own immune system to fight cancer.

Man and woman playing putt putt golf.



a subcutaneous injection, which means it's given under the skin. It isn't chemotherapy or an infusion.


a treatment you may receive at a nearby outpatient center that is able to administer EPKINLY.


 a treatment you can start as soon as you and your doctor are ready.


Ask your doctor if EPKINLY is right for you.


EPKINLY harnesses the power of my own immune system


EPKINLY is designed to target 2 types of cells in your body—T cells and B cells. 

Select each tile to learn more  

T cell beside b cell.


T Cells

T cells are immune cells that fight infections, as well as cancer cells.

T cell beside clump of cancerous B cells.


B Cells

B cells are another type of immune cell, and in DLBCL, some B cells can become cancerous and grow uncontrollably.

EPKINLY binding T cell and B cell together.



EPKINLY works by attaching to both your T cells and B cells, binding them together so that the T cells can attack and destroy B cells.

Get more information about treatment with EPKINLY.

Man and child playing game.

See how EPKINLY has worked for others.